2016

10732 bookmarks
Newest
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studies - PubMed
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studies - PubMed
Over 52 weeks, dapagliflozin provided glycaemic and weight benefits, with no increased frequency of severe hypoglycaemia compared with placebo. More DKA events were reported with dapagliflozin than placebo, highlighting the importance of appropriate patient selection, education and risk-mitigation s …
·pubmed.ncbi.nlm.nih.gov·
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studies - PubMed
Does Bible Give Us Clues Who PLANNED Trump Conspiracy? NOT WHO YOU THINK! - YouTube
Does Bible Give Us Clues Who PLANNED Trump Conspiracy? NOT WHO YOU THINK! - YouTube
Does the Bible give us clue who planned the Trump shooting? Yes, and it's not who you think? What evidence do we have that Thomas Michael Crooks had help? Where was the second shooter located? Click here to watch this extraordinary Nelson Walters video to help make sense of recent events in the USA AND what to overcome the events in our near future.
·youtube.com·
Does Bible Give Us Clues Who PLANNED Trump Conspiracy? NOT WHO YOU THINK! - YouTube
Long-term (52-week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT-2 study - PubMed
Long-term (52-week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT-2 study - PubMed
Efficacy and safety results from the Japanese subpopulation of the DEPICT-2 study were generally consistent with those from the overall population, indicating that long-term dapagliflozin adjunct to insulin therapy improves glycaemic control without an increased risk of hypoglycaemia but with a risk …
·pubmed.ncbi.nlm.nih.gov·
Long-term (52-week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT-2 study - PubMed
Efficacy and safety of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: A meta-analysis of randomized controlled trials - PubMed
Efficacy and safety of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: A meta-analysis of randomized controlled trials - PubMed
Sodium glucose cotransporter-2 (SGLT2) is a sodium-dependent glucose transporter responsible for renal absorption of glucose. Dapagliflozin is an SGLT2 inhibitor used in patients with type 1 diabetes to promote urinary glucose excretion, but to date, randomized controlled trials (RCTs) to evaluate t …
·pubmed.ncbi.nlm.nih.gov·
Efficacy and safety of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: A meta-analysis of randomized controlled trials - PubMed
Breastfeeding vs. Formula Feeding: What's Best for Your Baby? - YouTube
Breastfeeding vs. Formula Feeding: What's Best for Your Baby? - YouTube
Join us as we explore the age-old debate surrounding infant nutrition. In this video, we weigh the pros and cons of breastfeeding and formula feeding, providing evidence-based insights to help you make an informed decision for your baby's health. From nutritional benefits to practical considerations, we cover everything you need to know about these two feeding methods. Whether you're a new parent or simply curious about the science behind infant nutrition, this video is for you. #breastfeeding #baby #wellness Supercharge Your Health with Clinically Proven Nitric Oxide Solutions – Visit Now https://n1o1.com 🔔 Boost Your Health with Nitric Oxide: Unlock Its Secrets for Peak Performance & Wellbeing. Subscribe Now! https://www.youtube.com/@DrNathanSBryanNitricOxide/?sub_confirmation=1 ✅Important Links to Follow 🔗Linktree https://linktr.ee/n1o1 ✅ Stay Connected With Us. 👉Facebook: https://www.facebook.com/pneumanitricoxide/ 👉Instagram: https://www.instagram.com/n1o1.by.pneuma.nitric.oxide/ 👉Website: https://drnathansbryan.com/ ============================= ✅ Recommended Playlists 👉 Redefining Medicine - Dr. Nathan Bryan https://www.youtube.com/watch?v=iK9JzHpNdHM&list=PLZm8V0VIi2Y43P1qewE4uZv8mkpW_xm_Y&pp=iAQB 👉 Shorts https://www.youtube.com/watch?v=ztMZuUVyuHk&list=PLZm8V0VIi2Y6JJMHY7CeVvlOGVVAiQqhf&pp=iAQB ✅ Other Videos You Might Be Interested In Watching: 👉 Unlocking the Power of Nitric Oxide: Transforming Modern Medicine & Patient Care https://www.youtube.com/watch?v=tmj9FZqIV2g 👉 Disclosures and transparency on companies and products in which I am and am not involved. https://www.youtube.com/watch?v=o5kr_IeWnVk&t=18s 👉 Regenacast Podcast interview with Sean Berman of Cell Surgical Network. https://www.youtube.com/watch?v=9cwx4nIM9Mw&t=29s 👉 Sugar Crush Podcast with Dr. Rick Jacoby and Dr. Nathan S Bryan https://www.youtube.com/watch?v=cwo71eKe_Ic 👉 There is only one way to deliver nitric oxide to the human body. https://www.youtube.com/watch?v=nN2275k89ic ============================= ✅ About Dr Nathan Bryan Nitric Oxide. Nathan S. Bryan, Ph.D CEO/FOUNDER OF NO2U & NITRIC OXIDE LEADING EXPERT Dr. Bryan has made many seminal discoveries in the Nitric Oxide field, resulting in over a dozen U.S. and International patents. He is also a successful entrepreneur who has brought his Nitric Oxide technology to consumers. Dr. Bryan has published many highly cited papers and authored or edited five books. His work has made him a recognized international leader in molecular medicine and Nitric Oxide biochemistry. If your body can't make Nitric Oxide, we are here to help! 🔔 Nitric oxide: Your secret weapon for health, performance & longevity. Subscribe & unlock the knowledge! https://www.youtube.com/@DrNathanSBryanNitricOxide/?sub_confirmation=1 ================================= ⚠️DISCLAIMER: We do not accept any liability for any loss or damage incurred from you acting or not acting as a result of watching any of our publications. You acknowledge that you use the information we provide at your own risk. Do your research. Copyright Notice: This video and our YouTube channel contain dialogue, music, and images that are the property of Dr Nathan Bryan Nitric Oxide. You are authorized to share the video link and channel and embed this video in your website or others as long as a link back to our YouTube channel is provided. © Dr Nathan Bryan Nitric Oxide
·youtube.com·
Breastfeeding vs. Formula Feeding: What's Best for Your Baby? - YouTube
Dapagliflozin as an Adjunct Therapy to Insulin in Patients with Type 1 Diabetes Mellitus: Efficacy and Safety of this Combination - PubMed
Dapagliflozin as an Adjunct Therapy to Insulin in Patients with Type 1 Diabetes Mellitus: Efficacy and Safety of this Combination - PubMed
The prevalence of type 1 diabetes (T1D) is increasing worldwide. T1D reduces life expectancy due to complications including cardiovascular disease. Sodium-glucose co-transporter (SGLT) inhibitors are a new class of drugs developed to treat type 2 diabetes (T2D), and now they can be used as an adjunc …
·pubmed.ncbi.nlm.nih.gov·
Dapagliflozin as an Adjunct Therapy to Insulin in Patients with Type 1 Diabetes Mellitus: Efficacy and Safety of this Combination - PubMed
Dr. Ben Carson: The Left’s Worship of Kamala Harris, and God’s Mission for Donald Trump - YouTube
Dr. Ben Carson: The Left’s Worship of Kamala Harris, and God’s Mission for Donald Trump - YouTube
How was Kamala Harris transformed from an embarrassing incompetent to the coolest, most inspirational leader in the world in a single day? Dr. Ben Carson on America’s North Korean media landscape. Watch more here: https://watchtcn.co/49CDF2t Subscribe to the new Tucker Carlson Network channel for more exclusive content: https://www.youtube.com/@TCNetwork/featured?sub_confirmation=1 Follow Tucker on X: https://x.com/TuckerCarlson Text “TUCKER” to 44055 for exclusive updates. Paid partnerships: Hillsdale College: Find free online course at https://TuckerforHillsdale.com PureTalk Wireless: Save 50% off your first month at https://PureTalk.com/Tucker Get the Parler app: https://parler.com #TuckerCarlson #DrBenCarson #DonaldTrump #KamalaHarris #JoeBiden #election #Christianity #health #doctor #Detroit #riots #DEI #advice #news #politics Chapters: 00:00 Intro 02:21 Kamala Harris 11:53 Donald Trump 26:36 Why the Black Community Loves Trump 32:34 Communism, Marxism, and the Left’s New Religion 44:59 Dr. Carson’s Success, Family, and Marriage Advice 01:05:36 Living Through the Detroit Riots 01:18:28 Why are American Men So Unhealthy? 01:29:24 Is There Any Hope of Getting Back to a System That People Trust? 01:33:01 Why the Swamp Is Afraid of Trump 01:36:53 The Evils of Abortion
·youtube.com·
Dr. Ben Carson: The Left’s Worship of Kamala Harris, and God’s Mission for Donald Trump - YouTube
Fucoidan from Laminaria japonica protects renal tubular epithelial cells from uric acid induced NLRP3-mediated pyroptosis through inhibition of NF-κB pathway - ScienceDirect
Fucoidan from Laminaria japonica protects renal tubular epithelial cells from uric acid induced NLRP3-mediated pyroptosis through inhibition of NF-κB pathway - ScienceDirect
Hyperuricemia is a common metabolic disease with prominent morbidity, it can lead to many adverse effects and complications, such as chronic nephrosis…
·sciencedirect.com·
Fucoidan from Laminaria japonica protects renal tubular epithelial cells from uric acid induced NLRP3-mediated pyroptosis through inhibition of NF-κB pathway - ScienceDirect
Sean Hannity: President Biden and Vice President Kamala Harris have blood on their hands - YouTube
Sean Hannity: President Biden and Vice President Kamala Harris have blood on their hands - YouTube
Fox News host Sean Hannity unpacks Vice President Kamala Harris' record as she seeks the presidency on 'Hannity.' Subscribe to Fox News! https://bit.ly/2vBUvAS Watch more Fox News Video: http://video.foxnews.com Watch Fox News Channel Live: http://www.foxnewsgo.com/ FOX News Channel (FNC) is a 24-hour all-encompassing news service delivering breaking news as well as political and business news. The number one network in cable, FNC has been the most-watched television news channel for 18 consecutive years. According to a 2020 Brand Keys Consumer Loyalty Engagement Index report, FOX News is the top brand in the country for morning and evening news coverage. A 2019 Suffolk University poll named FOX News as the most trusted source for television news or commentary, while a 2019 Brand Keys Emotion Engagement Analysis survey found that FOX News was the most trusted cable news brand. A 2017 Gallup/Knight Foundation survey also found that among Americans who could name an objective news source, FOX News was the top-cited outlet. Owned by FOX Corporation, FNC is available in nearly 90 million homes and dominates the cable news landscape, routinely notching the top ten programs in the genre. Watch full episodes of your favorite shows The Five: https://www.foxnews.com/video/shows/the-five Special Report with Bret Baier: https://www.foxnews.com/video/shows/special-report Jesse Watters Primetime: https://www.foxnews.com/video/shows/jesse-watters-primetime Hannity: https://www.foxnews.com/video/shows/hannity The Ingraham Angle: https://www.foxnews.com/video/shows/ingraham-angle Gutfeld!: https://www.foxnews.com/video/shows/gutfeld Fox News @ Night: https://www.foxnews.com/video/shows/fox-news-night Follow Fox News on Facebook: https://www.facebook.com/FoxNews/ Follow Fox News on Twitter: https://twitter.com/FoxNews/ Follow Fox News on Instagram: https://www.instagram.com/foxnews/
·youtube.com·
Sean Hannity: President Biden and Vice President Kamala Harris have blood on their hands - YouTube
The Mystery of the Essenes | Ken Johnson & Josh Peck - YouTube
The Mystery of the Essenes | Ken Johnson & Josh Peck - YouTube
WATCH THE FULL CONVERSATION: https://www.youtube.com/watch?v=JXgdmz9QZ5E&t=230s We’re the Prophecy Watchers. We have a long history of working to bring the truth of Bible prophecy to an audience of Christian believers who may not have local access to sound prophetic teaching, based upon the inspired writings of the Apostles and the traditional doctrine concerning the rapture of the church. Though we don’t believe in setting dates, it is clear that the rapture of the church is imminent, perhaps much nearer than we think. DONATE: https://prophecywatchers.com/product/custom-donation-amount/ FIND US ON THE WEB: http://www.prophecywatchers.com TikTok: https://www.tiktok.com/@prophecywatchers IG: https://www.instagram.com/prophecy_watchers/ FOLLOW US ON FACEBOOK: http://facebook.com/prophecywatchers DOWNLOAD OUR APP: https://subsplash.com/prophecywatchers/app
·youtube.com·
The Mystery of the Essenes | Ken Johnson & Josh Peck - YouTube
Interview with Chief Joseph RiverWind (Genesis Apologetics) - YouTube
Interview with Chief Joseph RiverWind (Genesis Apologetics) - YouTube
To kickoff our new movie--"Out of Babel" (www.outofbabel.com), we wanted to interview our Native American consultants for the movie and friends, Chief Joseph RiverWind—a descendant of the Arawak Taino Tribe—and his wife, Dr. Laralyn of the Cherokee and Muskogee Creek. They tell a story about their special Journey to Israel were some meaningful things happened. Chief Joseph and Laralyn can be supported by visiting Firekeepers International (https://www.firekeepersinternational.org/)
·youtube.com·
Interview with Chief Joseph RiverWind (Genesis Apologetics) - YouTube
! 1 Dapagliflozin Pharmacokinetics Is Similar in Adults With Type 1 and Type 2 Diabetes Mellitus - PubMed
! 1 Dapagliflozin Pharmacokinetics Is Similar in Adults With Type 1 and Type 2 Diabetes Mellitus - PubMed
Dapagliflozin improves glycemic control in patients with type 2 diabetes mellitus (T2DM) and is approved in Japanese patients with type 1 diabetes mellitus (T1DM) with inadequate glycemic control. The objectives of this work were to characterize the dapagliflozin pharmacokinetics (PK) in patients wi …
·pubmed.ncbi.nlm.nih.gov·
! 1 Dapagliflozin Pharmacokinetics Is Similar in Adults With Type 1 and Type 2 Diabetes Mellitus - PubMed
A Network Meta-Analysis of the Dose-Response Effects of Dapagliflozin on Efficacy and Safety in Adults With Type 1 Diabetes - PubMed
A Network Meta-Analysis of the Dose-Response Effects of Dapagliflozin on Efficacy and Safety in Adults With Type 1 Diabetes - PubMed
Dapagliflozin 10 mg could achieve a better outcome in efficacy and could not increase the risk of hypoglycemia. Although it may induce a higher risk of DKA and genital infection, there was no significant difference between dapagliflozin 10 mg and 5 mg. Our outcomes indicate that dapagliflozin 10mg h …
·pubmed.ncbi.nlm.nih.gov·
A Network Meta-Analysis of the Dose-Response Effects of Dapagliflozin on Efficacy and Safety in Adults With Type 1 Diabetes - PubMed
Insulin dose reduction in dapagliflozin combination therapy for type 1 diabetes mellitus: the RISING-STAR study - PubMed
Insulin dose reduction in dapagliflozin combination therapy for type 1 diabetes mellitus: the RISING-STAR study - PubMed
To clarify the frequency of hypoglycemia in patients with type 1 diabetes mellitus receiving dapagliflozin combination therapy to reduce their basal insulin dose. Sixty subjects were assigned to two groups according to their basal insulin-to-total daily dose (TDD) ratio: group A (basal insulin/TDD & …
·pubmed.ncbi.nlm.nih.gov·
Insulin dose reduction in dapagliflozin combination therapy for type 1 diabetes mellitus: the RISING-STAR study - PubMed
A Possible Novel Effect for Dapagliflozin in the Management of Subcutaneous Insulin Resistance Syndrome: A Report of Two Cases - PubMed
A Possible Novel Effect for Dapagliflozin in the Management of Subcutaneous Insulin Resistance Syndrome: A Report of Two Cases - PubMed
These are the first reported cases of SIRS in which dapagliflozin, an SGLT-2 inhibitor, was used. The substantial reduction in the IM insulin dose following the addition of dapagliflozin in our reported cases of SIRS suggests a possible novel mechanism for dapagliflozin beyond its glucosuric effects …
·pubmed.ncbi.nlm.nih.gov·
A Possible Novel Effect for Dapagliflozin in the Management of Subcutaneous Insulin Resistance Syndrome: A Report of Two Cases - PubMed
Clinical studies of dapagliflozin in pediatric patients: a rapid review - PubMed
Clinical studies of dapagliflozin in pediatric patients: a rapid review - PubMed
The oral sodium-glucose cotransporter 2 inhibitor, dapagliflozin, is used to treat kidney disease, heart failure, and diabetes in adults, but has not been well studied in pediatrics, and does not have a recognized place in therapy in current practice guidelines. The purpose of this review is to summ …
·pubmed.ncbi.nlm.nih.gov·
Clinical studies of dapagliflozin in pediatric patients: a rapid review - PubMed
Efficacy of Low-dose Dapagliflozin in Young People with Type 1 Diabetes - PubMed
Efficacy of Low-dose Dapagliflozin in Young People with Type 1 Diabetes - PubMed
Objective Young people with type 1 diabetes are likely to gain body weight and not achieve optimal glycemic control with only high doses of insulin. This study examined the efficacy of the sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin as an adjunct-to-insulin therapy in young Japane …
·pubmed.ncbi.nlm.nih.gov·
Efficacy of Low-dose Dapagliflozin in Young People with Type 1 Diabetes - PubMed
Therapeutic effect and rebound evaluation of dapagliflozin on glycated hemoglobin (HbA1c) in type 1 diabetes mellitus patients - PubMed
Therapeutic effect and rebound evaluation of dapagliflozin on glycated hemoglobin (HbA1c) in type 1 diabetes mellitus patients - PubMed
Dapagliflozin has been used to treat patients with type 1 diabetes mellitus; however, the actual drug efficacy of dapagliflozin on glycated hemoglobin (HbA1c) and whether there is a rebound from dapagliflozin efficacy on HbA1c remain unknown. The present study aimed to explore the actual therapeutic …
·pubmed.ncbi.nlm.nih.gov·
Therapeutic effect and rebound evaluation of dapagliflozin on glycated hemoglobin (HbA1c) in type 1 diabetes mellitus patients - PubMed
The prophetic implications of Iran & Proxies vs. Israel - YouTube
The prophetic implications of Iran & Proxies vs. Israel - YouTube
This 15 minute video is filled with prophetic morsels and topped off with Marsalus sauce. LA Marzulli connects with Bill Salus at the Prophecy Watchers Colorado Conference in June 2024. Although a short visit, they covered several topics including, the destruction of Damascus in Isaiah 17, Iran and its potential nuclear capabilities, Ezekiel 38 and also the Rapture. Thanks For Watching! Click the bell icon next to the SUBSCRIBE button to get alerts when a new video is uploaded. Visit Website: http://prophecydepot.com Read Daily News Reports: http://prophecynewsstand.blogspot.com Subscribe to Newsletter: http://prophecydepotministries.net Bill's Articles: http://prophecydepotministries.net/bills-articles/ Products: http://ecommerce.solutionsimplicity.com/index
·youtube.com·
The prophetic implications of Iran & Proxies vs. Israel - YouTube
! 1 Benefit or Risk in Patient with Type 1 Diabetes Based on Appropriated Dosage of Dapagliflozin: A Case Report - PubMed
! 1 Benefit or Risk in Patient with Type 1 Diabetes Based on Appropriated Dosage of Dapagliflozin: A Case Report - PubMed
Purpose: Dapagliflozin has been used extensively in patients with type 2 diabetes mellitus (T2DM). However, due to the potential diabetic ketoacidosis (DKA) risk of dapagliflozin, its use in type 1 diabetes mellitus (T1DM) is limited. Here, we reported an obese patient with T1DM and inadequat …
·pubmed.ncbi.nlm.nih.gov·
! 1 Benefit or Risk in Patient with Type 1 Diabetes Based on Appropriated Dosage of Dapagliflozin: A Case Report - PubMed
! 1 Effects of dapagliflozin on renal function in type 1 diabetes patients in the real world: A retrospective multicenter study of the KAMOGAWA-A cohort - PubMed
! 1 Effects of dapagliflozin on renal function in type 1 diabetes patients in the real world: A retrospective multicenter study of the KAMOGAWA-A cohort - PubMed
At 24 months, the decline in eGFR was significantly lower in the dapagliflozin group than in the non-use group without increasing diabetic ketoacidosis and hypoglycemia.
·pubmed.ncbi.nlm.nih.gov·
! 1 Effects of dapagliflozin on renal function in type 1 diabetes patients in the real world: A retrospective multicenter study of the KAMOGAWA-A cohort - PubMed